Behind the Scenes of a Billion Dollar Pharma Deal
On 9 June 2020 Eli Lilly and Evox Therapeutics inked a neuroscience therapy deal worth $1.2 billion.
In this webinar two of the key players in that deal will take you behind-the-scenes to explain how Evox got on Lilly’s radar, explore the challenges of forming a partnership under a COVID-19 lockdown, and recall the discussions and internal debates that led to one of the biggest biopharma deals of the year so far.
Please complete the form below
All fields marked with a * are required.
personal data by Inova Software as detailed in the Privacy Statement.
Our cloud-based solutions help life science companies manage
their biopharma opportunities more efficiently. They find all their
partnering information in one place, track their deals and alliances
easily and report on their pipeline and activities in seconds.
the 20 biggest biopharma events automatically available in Inova,
providing our users with always up-to-date company and contact
information. Over 150 life science companies, including 50% of the
top 50 pharmaceutical companies and many midsize pharma and
innovative biotechs already use Inova.